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INTRODUCTION 
On Monday, Jan. 3, 1972, Dr. Pierre Ardoin, Director of the 
Trinidad Regional Virology Laboratory (TRVL), University of the 
West Indies, reported to the Center for Disease Control (CDC), 
Atlanta, Georgia, that since Dec. 6, 1971, his laboratory had 
isolated type 1 poliovirus from 27 of 48 patients with suspected 
poliomyelitis in Trinidad. 
The next day, L. Schonberger, M.D., of the Viral Diseases 
Branch, Epidemiology Program, CDC, discussed this outbreak of 
poliomyelitis in Trinidad with Dr. Mervyn Henry, Chief Medical 
Officer, Trinidad Ministry of Health. 	It was agreed that Trinidad 
was probably on the verge of a major poliomyelitis epidemic and 
that an ongoing epidemiologic study was needed. A national vacci-
nation campaign, using monovalent type 1 oral poliovirus vaccine 
and directed at children under 4 years of age was tentatively 
planned for January 8 and 9. This was subsequently changed to 
trivalent oral vaccine for children 3 months to 6 years of age, 
(See Immunization Campaign section). Grammar schools were to 
be closed following the Christmas-New Year holiday, until a 
school vaccination program and serologic study could be organized. 
A decision was made on January 5, to send Dr. Schonberger to 
Trinidad under the auspices of the Pan American Health Organization 
(PAHO) to assist with the poliomyelitis outbreak. Milford H. Hatch, 
Sc.D., Chief, Enteric Virology Unit, Laboratory Division, CDC, would 
join Dr. Schonberger to offer laboratory support. They arrived in 
Trinidad on January 8. Dr. Hatch remained until January 25, and 
Dr. Schonberger remained until February 6. 
DESCRIPTION OF THE AREA  
The island of Trinidad and its smaller sister island, Tobago, 
constitute an independent member nation of the British Commonwealth. 
The country lies 6 1/2 miles from the coast of Venezuela in the 
southern Caribbean. The climate is tropical; January to June is dry, 
and July to December is rainy. Second largest of the former British 
West Indies, Trinidad is about 65 miles at its greatest width, 50 
miles at its greatest length, and has an area of 1,864 square miles. 
Its 1972 population is 949,200. Approximately 44 percent of the 
population is of African ancestry, 36 percent East Indian, 2 percent 
European, 1 percent Chinese, 1 percent Middle-Eastern and 16 percent 
mixed ancestry. Religions include Roman Catholic (36%), Protestant 
(34%), Hindu (23%), and Moslem (6%). 
There are eight counties consisting of 29 wards plus three major 
municipalities: Port-of-Spain (population 71,145), San Fernando 
(population 39,109), and Arima Borough (population 12,363). These 
three cities and the three wards adjacent to Port-of-Spain and San 
Fernando constitute the major concentrations of population in Trinidad. 
The rest of the island is largely agricultural with sugar cane, citrus, 
copra, and cocoa being most important in terms of dollar value and employment. 
The island of Tobago (41,300 population) is northeast of Trinidad, 
across a channel 19 miles wide, and constitutes a ninth county of the 
two island nation. Tobago is 32 miles long and 11 miles wide with an 
area of 116 square miles. Travel between the islands is restricted to 
those who can afford it. A round-trip fare from Port-of-Spain is $7.00 
by boat and $24.00 by airplane, No poliomyelitis cases were reported 
from Tobago at the time of the epidemic in Trinidad. 
The nation's infant mortality dropped from 62 per thousand in 1959 
to 37 per thousand in 1968. 	Its birth rate fell from 39 per thousand to 
27,5 per thousand, and its over-all death rate dropped from 14 per thousand 
to 7 per thousand from 1946 to 1968. 	In the 3-year period 1965-1968, the 
average annual population growth was 1.6 percent, representing a significant 
drop from the 2.9 percent for the period 1946-1960. The population is young; 
over 50 percent of the people on the island of Trinidad are under 20 years of 
age, and 35 percent are under 13, 
THE HISTORY OF POLIOMYELITIS IN TRINIDAD 
Poliomyelitis has existed in Trinidad in endemic form with periodic 
major outbreaks for at least 35 years. Table 1 shows the incidence of 
poliomyelitis from 1935 to 1971, 	Major outbreaks occurred in 1937, 1941, 
1942, 1945, 1954 and 1957. 	In all but five of the 31 other years listed, 
the number of cases was below 10, The disease has shown a recurrence in 
serious epidemic form at irregular intervals, ranging from 2 to 14 years. 
Trinidad's last major poliomyelitis outbreak from February to August 1957, 
like the present outbreak, was caused by type 1 poliovirus. A total of 
300 cases were reported from widely scattered areas throughout the island. 
Trinidad's first mass poliomyelitis vaccination campaign was conducted 
in 1963, stimulated largely by an increase in the number of cases that year. 
Official reports showed that 234,400 children under 10 years old, or 96.6 
percent of the target population, received two doses of trivalent oral vaccine. 
The country's second and most recent mass vaccination program was 
conducted in mid 1967, stimulated by polio outbreaks in neighboring 
continental South America. A total of 54.9 percent of children 3 months 
to 5 years of age received at least one dose of trivalent oral poliovirus 
vaccine, and 41.6 percent received two doses. 
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Since mid-1967, vaccination has been inadequate. As of December 
1971, less than 10 percent of the children in Trinidad born after the 
1967 vaccination campaign had received even one dose of poliovirus 
vaccine from the government. (Data regarding vaccinations by private 
physicians are not available.) 
METHOD OF CASE FINDING 
The diagnosis of poliomyelitis was based on either demonstrable 
flaccid paralysis of acute onset (198 cases) or meningitis and a positive 
stool culture for type 1 polio (7 cases). 
Poliomyelitis cases from all areas of Trinidad were referred to two 
hospitals, Port-of-Spain General (800 beds) and San Fernando General (700 
beds) because other hospitals preferred not to treat them. This made 
possible a reasonably complete and accurate count of hospitalized cases. 
Tobago had its own hospital in the city of Scarborough; however, contact 
with that island every 3 days during the epidemic failed to reveal any 
new cases. 
After arriving in Trinidad, the writer attempted to obtain a complete 
list of poliomyelitis cases in patients who had already been admitted to 
the hospitals and set up a centralized surveillance system for identifying 
new poliomyelitis cases soon after their hospital admission. A list of 
patients with suspected poliomyelitis was obtained from Dr. Oswald Siung, 
Principal Medical Officer of Health, who had been regularly calling his 
own hospital contacts. The diagnoses of the patients were checked and 
additional cases were identified by interviewing hospital physicians, and 
reviewing TRVL and hospital records. With the help of M. Henry, M.D., 
P. Ardoin, M.D., and PAHO Representative Colm O'Colman, headquarters for 
a surveillance system was established at TRVL equipped with a Trinidad 
Ministry of Health phone, a PAHO secretary, and Dr. Ardoin's University 
of West Indies furniture and maps. 	I. Mohammad, M.D., Chief of Infectious 
Diseases at San Fernando General Hospital, or his close associate, R. Cox, 
M.D., Pediatrician, and a surveillance nurse from Port-of-Spain General 
Hospital called the headquarters daily to report newly identified polio-
myelitis cases. 
Primarily responsible for identifying new poliomyelitis cases at San 
Fernando were Dr. Mohammad and Dr. Cox who examined all the suspect cases. 
At Port-of-Spain, the responsibility was shared by two pediatric consultants, 
Dr. McDowall and Dr. Ramkissoon, and four medical consultants, Dr. Quamina, 
Dr. Ince, Dr. Bartholomew and Dr. Ratan. Poliomyelitis case report forms 
were provided at both hospitals to facilitate collection of the following 
information: poliomyelitis patient's name, age, sex, home address, date of 
onset of illness, date first seen, vaccination history, location of paralysis, 
name of reporting physician. 
At both hospitals, though primarily at Port-of-Spain General, the 
writer reviewed charts and examined patients. Reports of several home 
visits were collected from Medical Officer of Health, Stella Abidh. By 
February 6, information on 205 hospitalized poliomyelitis cases had been 
collected. Chief sources of information on these cases were: a) hospital 
chart reviews, 123 cases; b) home visit reports, 5 cases; c) hospital 
report forms, 64 cases; d) initial physician interviews, 11 cases; and 
e) Trinidad Regional Virology Laboratory reports, 2 cases. 
The surveillance system missed some paralytic poliomyelitis patients 
who were cared for by private physicians outside the hospital. Two such 
patients were revealed in a survey of 39 out of 237 private physicians 
in Trinidad on January 13 and 17, when approximately 125 hospitalized polio-
myelitis cases had been identified. No regular concerted effort was made 
to determine non-paralytic poliomyelitis cases. 
THE POLIOMYELITIS EPIDEMIC 
The date of admission to the hospital was obtained for all 205 patients 
(Figure 1) and the date of onset for 178. The interval between date of onset 
and date of admission for these 178 cases is shown in figure 2. By randomly 
distributing the 27 unknown intervals between onset and hospital admission 
so that they corresponded to the distribution of the 178 known intervals, an 
epidemic curve by week of onset was derived (Figure 3). 
The first case, as shown in figure 3, occurred in the week ending 
October 10, 1971. This patient lived in the sparsely populated eastern 
Trinidad ward of Cocal. The second case was in a 2-year-old boy from 
Laventille who became ill in the week ending November 21. Laventille 
(21,000 population) is a poor working class district of St. Ann's Ward 
near the city of Port-of-Spain. Neither of the first two poliomyelitis 
cases nor their close contacts had recently traveled more than several 
miles from home. In the next 2 weeks, November 22-December 5, 10 more 
children had onset of poliomyelitis who were subsequently hospitalized. 
Eight of them lived in Laventille or adjacent areas, and two lived in 
eastern Trinidad. The first type 1 polioviruses of the epidemic were 
isolated from stool specimens from seven of these cases. Through the 
week ending January 2, the number of cases steadily increased, and then 
rose sharply in the week ending January 9. The epidemic peaked in the 
following week. 
Of the 46 patients who became ill before December 27, 33 lived in 
St. Ann's Ward or adjacent Port-of-Spain (Figure 4). The more rapid 
increase in new cases (108) seen from December 27 to January 16 represented 
both an increase in the number of new cases in most of the previously 
affected areas and a spread of the disease throughout the island (Figure 5). 
Areas reporting cases for the first time between December 27 and January 16 
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included Arima Borough, Manzanilla, San Fernando, LaBrea, Erin, Naparima, 
and Moruga. Of these Manzanilla, Naparima, and Moruga reported three or 
more cases. The largest number of new cases (27) continued to come from 
St. Ann's Ward. 
In the 3-week period January 17-February 6, the epidemic waned (51 
new cases). In contrast to the early spread of the disease, most of these 
cases came from Siparia Ward in the South rather than from St. Ann's Ward. 
Couva, Montserrat and Arima Wards reported cases for the first time, while 
no new cases came from Laventille, Manzanilla, or Charuma (Figure 6). 
The overall attack rate per 100,000 population was 21.6. Cocal, 
Laventille, and Moruga had considerably higher attack rates per 100,000 
than the other areas of the country, 92.6, 90.5, and 57.7 respectively. 
Cocal and Moruga are sparsely populated wards in the southern half of 
Trinidad, in contrast to Laventille which is a densely populated district 
of northern Trinidad. The area with the fourth highest attack rate, Charuma 
ward (40.9 cases per 100,000 population), lies adjacent to Cocal ward and 
is also relatively sparsely populated. The largest number of cases, whether 
or not Laventille is included, lived in the most densely populated ward in 
Trinidad, St. Ann's (Figure 7). 
Patients ranged in age from 5 weeks to 33 years (mean, 3 years). 
Over 75 percent of the cases were in persons less than 7 years of age, 
and over 90 percent of the cases were less than 13 (Figure 8). By February 
6, type 1 poliovirus had been isolated at TRVL from 99 of 152 patients. The 
age distribution of those with positive cultures is shown in figure 8. Age 
specific attack rates are shown in table.;. Relative to tk youngest age 
group, the ttack rate was approximatelyn 146 greater 	the 7 to 12- 
year-olds, Y11 tibia greater 41114tthe 13 to 18 year-olds, andYS5 	i, greater 
far'` those 19 years and older. The male and female-specific attack rates per 
100,000 population were 23.9 and 19.4 respectively (Table 3). Males pre-
dominated in all age groups except the 13 to 18-year-olds. Of the 205 polio-
myelitis cases identified, 46.3 percent had East Indian surnames. Since 
approximately 44 percent of the population in Trinidad have East Indian 
surnames, the overall data shows no significant predilection of this group 
for the disease. 
Primarily by reviewing hospital charts at Port-of-Spain General, the 
investigator obtained information on the prodromal symptoms of 126 patients. 
The most common symptoms were fever (94.4%), vomiting (36.5%), coughing 
(24.6%), headache (21.4%), muscle aches (15.9%), and stiff neck (10.3%). 
Eleven patients (5.4%) were known to have bulbar disease, and four 
died, Five of these had paralysis of a seventh cranial nerve, and four 
had paralysis of a tenth cranial nerve. One patient was reported to have 
vaso-motor involvement, and another respiratory center involvement. 
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Eleven of the 205 hospitalized poliomyelitis patients died (case 
fatality ratio, 5.4%). Ten of the deaths were in the 0-6 year age group 
(case fatility ratio, 6.5 percent), and one of the deaths occurred in the 
> 19 year age group (case fatility ratio, 12.5%). The diagnoses of polio-
myelitis was confirmed by virus isolation for eight of the 11 fatalities. 
Type 1 poliovirus was isolated from brain tissue from two fatal cases, 
including the one adult. The immediate cause of death was noted in nine 
of the 11 cases. Seven had primary respiratory failure, one bulbar shock, 
and another pneumonia complicating respiratory insufficiency. 
An interesting feature of this epidemic was the marked difference in 
the distribution of cases by race and age between the northern and southern 
parts of Trinidad. 	(The arbitrary border between North and South Trinidad 
is a line made by the northern borders of Couva, Montserrat, Charuma and 
Cocal Wards. The South comprises 54.2 percent of the Island, but has only 
43.4 percent of the population.) A total of 62 of 84 poliomyelitis cases 
in the South (73.8%) had East Indian surnames, compared with 33 of 121 
cases in the North (27.3%). Poliomyelitis cases by age for northern and 
southern Trinidad is shown in table 4. The accuracy of the age specific 
attack rates depends on the assumption that the age distribution of the 
population in the two sections of the country are the same. Attack rates 
for the North and South were significantly different for every age group 
except adults > 19 years of age. 
The age distributions of poliomyelitis cases among East Indians and 
others in the South were more similar to each other than they were to the 
age distributions of poliomyelitis cases in either group in the North. 	In 
other words, location of residence rather than race correlated better with 
the age distribution of the poliomyelitis cases. 
DISCUSSION 
The progression of the poliomyelitis epidemic in Trinidad suggests 
that national holidays may pose a potential danger to the containment of 
small poliomyelitis outbreaks. 	It was probably no coincidence that the 
major spread of the epidemic occurred during a poliomyelitis incubation 
period (3-21 days) after Christmas. During the holiday period, buses 
and cars were filled with people traveling throughout the Island to visit 
friends and family. At least four of the patients from four different 
wards in Trinidad became ill several days after visiting together over the 
Christmas vacation. The father of a fifth poliomyelitis patient with onset 
January 8, visited over the Christmas vacation, the home of another child 
who had been ill with poliomyelitis for 1 day. 
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Assuming that the calculated age specific attack rates in North and 
South Trinidad are correct, and that bias in the surveillance system was 
small, the higher attack rate for the children under 7 in the North appears 
to reflect the earlier more rapid urban spread of the epidemic there and 
the subsequent greater protection of children in the South by vaccinations. 
(See Campaign Effectiveness section) 
The higher attack rates in the South among the children 7-12 and 
13-18 suggest that the mass vaccination programs in 1963 and 1967, which 
provided two doses of oral poliovaccine to 96.6 percent and 41.6 percent 
of the target populations respectively, was less successful in the South 
than in the North. The present ages of children vaccinated in the 1963 
and 1967 campaigns would be 9 1/4 to 18 years, and 5 1/4 to 9 years 
respectively. With the tropical heat of Trinidad, the greater time needed 
to transport vaccine from the government's central vaccine stores to the 
southern population, and the inadequate supply of freezers in the South, 
a greater use of spoiled vaccine in previous vaccination campaigns in the 
South relative to the North would not be unexpected. The frequent need 
for guidance in the storage of vaccine in the present vaccination campaign 
led to the Ministry of Health publishing recommendations written by Dr. 
M. Hatch. 
Appropriate denominatior data is not available from the government for 
analysis of the distribution of the poliomyelitis cases with East Indian 
surnames. The higher proportion of these cases in the South, however, 
probably reflects to a large degree the distribution of East Indians in 
the country as a whole. According to a Trinidad government official, East 
Indians comprise a greater proportion of the agricultural workers than city 
workers in Trinidad. The greater number of poliomyelitis cases in East 
Indians in the South, therefore, might also indicate a rural location of 
the epidemic there. 
IMMUNIZATION CAMPAIGN 
A vaccination program had been planned to start December 22 in St. 
George County and Port-of-Spain, but it was not successful because of an 
unaroused public, inadequate vaccine supplies, and the Christmas holidays. 
The first national campaign was started on January 8, with approximately 
800 people staffing over 300 vaccination centers. Children ages 3 months 
to 6 years, who were considered to be at highest risk, were selected as 
the initial target population. By January 10, 89,499 or 55.6 percent of 
the target population in Trinidad received one dose of oral poliovirus 
vaccine. This figure was raised to 81.5 percent after a "wrap up" 
vaccination campaign for this age group was conducted January 22 and 23. 
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The Ministry of Health chose trivalent, rather than monovalent oral 
poliovirus vaccine, because of the frequent isolation of type 2 poliovirus 
prior to the epidemic. Though there were less than 1,000 doses of oral 
vaccine in government stores on December 22, the Ministry of Health obtained 
140,000 doses of trivalent and 25,000 doses of monovalent oral poliovimth 
vaccine by January 7 and an additional 410,000 doses of trivalent vaccine 
on January 8. Vaccine received January 8 was distributed immediately to 
local health centers by Ministry of Health personnel who worked throughout 
the night. 
A campaign for the 7 to 12 year-olds was conducted from January 13 to 
January 18 at temporarily opened schools. This campaign reached 138,507 
children or 84.3 percent of the target population. 
Beginning January 27, the Medical Officers of Health in the South 
vaccinated the 12 to 18 year olds in schools, and were followed by the 
Medical Officers of Health in the North who vaccinated this age group 
during the first week in February. Adults meanwhile were offered vaccine 
at the local health centers. Based on the information available February 
6, 1972, the percentage of target populations who received vaccine by 
various dates is listed in table 5. The numbers do not include vaccinations 
performed by private physicians. 
Thirty-nine of Trinidad's 237 practicing physicians submitted completed 
questionnaires on January 13 and January 17 stating that they had vaccinated 
19,963 individuals of all ages since the beginning of the epidemic. 	If this 
sample were representative, an estimated 2 percent of Trinidad's population 
was recently vaccinated by private physicians. The vast majority of these 
vaccinations were, presumably, in middle and upper income children and adults 
who elected not to wait for government provided vaccine. 
CAMPAIGN EFFECTIVENESS 
After the government's national vaccination campaign, there was a 
rapid decline in the total number of reported new cases (Figures 1 and 3). 
The attack rate for children from 3 months to 6 years of age who had been 
vaccinated by the government between December 22 and January 10 fell sooner 
and more rapidly than the attack rate for those who were not vaccinated in 
this period (Figure 9). 	In the second week after this vaccination campaign, 
the attack rate for the unvaccinated children was 17.6 per 100,000, compared 
with 5.6 for the vaccinated children. This supports the contention that the 
mass vaccination program using primarily trivalent oral poliovirus vaccine 
effectively curtailed this type 1 poliomyelitis epidemic. 
The effectiveness of the initial mass vaccination campaign January 
8-10 in South Trinidad was greater than in North Trinidad. The campaign 
in the South reached a higher percentage of the target population, 66.7 
percent compared with 47.0 percent. This probably resulted because over 
75% of the vaccination centers were established in the South due to different 
strategies among Medical Officers of Health. Furthermore the campaign in 
the South relative to the epidemic in the South was conducted earlier than 
the campaign in the North relative to the epidemic there 	(Figure 10 and 11), 
The 6723 vaccinations completed by January 10 in Caroni County were arbitrarily 
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divided between North and South in the same proportion as the division of 
its population. Of the 107 poliomyelitis cases in North Trinidad under 7 
years of age, two younger than 3 months and a 2-year-old child with an 
unknown vaccination history were not included in figures 9 and 11. 
The effectiveness of the initial vaccination campaign is probably 
underestimated since the denominator of the vaccinated group does not 
include the children vaccinated by private physicians (figures 9, 10 
and 11). 	In addition, many children not vaccinated in the government's 
initial campaign were protected by vaccinations given later. 
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RECOMMENDATIONS 
1. The Ministry of Health should work towards vaccinating its 
infant population on routine visits to well-baby clinics. To achieve 
this, the Ministry needs to acquire more trained personnel, to supply 
and maintain improved equipment (such as freezers for its clinics), 
and most importantly to increase and maintain an ongoing educational 
campaign emphasizing the importance of the free services offered at 
the well-baby clinics in Trinidad. 
2. If routine vaccinations reach less than 75 percent of the 
infants in the population, then Trinidad should consider having at 
least two week-end mass campaigns each year, with an interval of not 
less than 6 weeks between each, in which all children between the ages 
of 2 months and 3 years receive trivalent oral poliovirus vaccine. 
If insufficient numbers of parents bring their children to vaccination 
centers during mass campaigns, then Trinidad should consider house-to-house 
vaccinations utilizing community volunteers. This recommendation should be 
received with the understanding that the minimum percentage of the infant 
population in Trinidad who must be vaccinated in order to prevent another 
poliomyelitis epidemic is not known. 
3. Legislation requiring immunization against poliomyelitis prior to 
school entry is recommended. 
4. The positions of Medical Officers of Health are extremely important 
in Trinidad and immediate steps to attract newly trained people to the 
present vacancies should be given high priority. 
5. A more uniform and disciplined reporting system for poliomyelitis 
(and other reportable diseases) should be established. 
6. Simple, but regular surveillance reports from the Ministry of 
Health summarizing the available information on poliomyelitis and other 
reportable diseases should be sent to the Medical Officers of Health and 
to private physicians. 
7. The basic population statistics at the Ministry of Health should 
be kept up to date and distributed to the Medical Officers of Health on a 
regular basis. 
8. The Ministry of Health should offer greater support and take 
greater advantage of the Trinidad Regional Virology Laboratory. The Chief 
Medical Officer should be appraised regularly of information gathered 
through this source. 
9. To evaluate the poliomyelitis immunologic status of Trinidad's 
population, regular serologic surveys should be conducted in cooperation 
with TRVLO 
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10. Contingency plans for increasing and or reassigning Ministry 
of Health personnel for possible future epidemic situations should be 
made. 
11. More resources, such as more physical therapists and physical 
therapy equipment, should be provided for the long range treatment of 
the poliomyelitis patients. 
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RECOMMENDATIONS FOR THE PAN AMERICAN HEALTH ORGANIZATION (PAHO)  
1. Trained technicians should routinely accompany respirators 
supplied to a country with a poliomyelitis outbreak, unless there is 
overwhelming evidence that the technicians will not be needed. The 
technicians should be capable of instructing others in the use of the 
machines. 
2. PAHO should provide written information on the use and storage 
of poliovirus vaccine to countries experiencing poliomyelitis epidemics. 
3. PAHO should publicize poliomyelitis vaccination requirement guide-
lines for international travel from epidemic areas to potentially susceptible 
non-epidemic areas. 
4. PAHO should establish a regional store-house of vaccine located 
at the TRVL in order to avoid the delays caused by international negotiations 
whenever vaccine is needed in the Southern Caribbean area and to avoid 
important lapses in availability of vaccine. Furthermore, TRVL should 
test stored vaccines to assure their potency. 
TABLE 1 
OFFICIALLY REPORTED POLIOMYELITIS 
CASES BY YEAR, TRINIDAD 
YEAR CASES 
1935 	to 	1971 
YEAR CASES 
1935 5 1953 2 
1936 6 1954 189 
1937 106 1955 16 
1938 9 1956 9 
1939 5 1957 300 
1940 3 1958 27 
1941 59 1959 15 
1942 135 1960 3 
1943 9 1961 3 
1944 4 1962 12 
1945 99 1963 15 
1946 5 1964 4 
1947 5 1965 0 
1948 8 1966 1 
1949 8 1967 3 
1950 1 1968 1 
1951 3 1969 9 
1952 6 1970 3 
1 971 2 
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Table 2 







0-6 154 92.2 
7-12 31 18.9 
13-18 12 8.66 
> 	19 8 1.67 
TOTAL 205 21.6 
Rate per 100,000 pop. 
Table 3 
POLIOMYELITIS CASES, BY 





0-6 79 75 
7-12 21 10 
13-18 4 8 
> 	19 8 0 
TOTAL 112 93 
Sex specific 
attack 	rates 




POLIOMYELITIS CASES, BY AGE GROUPS, 
NORTH AND SOUTH TRINIDAD, 1971-1972 
AGE GROUPS NORTH TRINIDAD 
CASES 	ATTACK RATE* 
SOUTH TRINIDAD 
CASES 	ATTACK RATE* 
0-6 107 113 47 64.8 
7-12 9 9.69 22 30.9 
13-18 2 2.55 10 16.6 
> 	19 3 1.11 5 2.40 
TOTAL 121 22.5 84 20.4 
*Assumes age distributions of populations in North and South Trinidad are 
the same. 
Rate per 100,000 pop. 
Table 5 
PERCENTAGE OF TARGET POPULATION WHO RECEIVED 
VACCINE BY DATE, TRINIDAD, 1972 
AGE GROUPS DATE NUMBER VACCINATED PERCENTAGE VACCINATED 
Jan 10 89,499 55.6 
3 mos.-6 yrs. Jan 23 131,261 81.5 
Jan 29 132,080 82.0 
7 yrs.-12 yrs. Jan 18 138,507 84.3 
Jan 30 139,651 85.0 
Figure / POLIOMYELITIS CASES, BY WEEK OF 
ADMISSION TO HOSPITAL, TRINIDAD, 
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Figure 2 POLIOMYELITIS CASES, BY INTERVAL BETWEEN ONSET AND HOSPITAL 
ADMISSION, TRINIDAD, OCTOBER 6, 1971- FEBRUARY 6, 1972 
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Figure 3 	POLIOMYELITIS CASES, BY WEEK OF ONSET, TRINIDAD, 
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Figure 8 POLIOMYELITIS CASES, BY AGE, TRINIDAD, OCT. 6, 1971-FEB. 6, 1972 
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Figure 9 POLIOMYELITIS AGE SPECIFIC ATTACK RATES IN 3 MOS. — 
6 YEAR OLDS, BY WEEK, TRINIDAD, NOV. 8, 1971-JAN. 31,1972 
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VIROLOGICAL STUDIES 
A. Performed at the Trinidad Regional Virus Laboratory (TRVL), 
Port-of-Spain, Trinidad. 
Fifteen of the 30 polioviruses isolated by the Government Diagnostic 
Virus Laboratory (GDVL) and the TRVL up to the time of our arrival in 
Trinidad were tested by the neutralization method against poliovirus 
types 1, 2, and 3 antisera brought from the Center for Disease Control 
in Atlanta. All 15 viruses were confirmed as poliovirus type 1. One 
poliovirus isolant previously made at TRVL and identified as a type 2 
virus was confirmed as a type 2 with antisera brought from Atlanta. 
Eight rectal swabs submitted to TRVL for viral isolation studies 
were processed by a simultaneous isolation and identification procedure 
for polioviruses, using primary rhesus kidney tissue cultures. Two 
specimens yielded poliovirus type 1 (one on the 4th day after inoculation, 
one on the 5th day). A third specimen yielded a virus which required 
further tests for identification. 
Samples of brain and spinal cord from two fatal cases diagnosed as 
poliomyelitis were studied by a special agar overlay isolation technique 
using HEp-2 tissue culture. Plaques were observed with all the specimens. 
Viruses were isolated from the plaques, passed in primary rhesus kidney 
cultures and typed by neutralization tests as poliovirus type 1. 
Tests were carried out to gain a preliminary idea of the incidence of 
neutralizing antibody to poliovirus type 1 in school age children. 
Forty-six pairs of sera (92 total sera) from children ages 6 to 14 years 
from different parts of Trinidad were tested for poliovirus type 1 
neutralizing antibody at 1:8 serum dilution using HEp-2 tissue cultures. 
Initial sera were collected for previous TRVL studies; the second sera 
were collected during the time of the poliomyelitis outbreak by TRVL 
personnel. Results are shown in Table 1. 
In the tests of the sera from Vega de Oropouche school, the test dose of 
poliovirus type 1 was too high (1000TCID50). This probably depressed the 
number of individuals showing antibody in this group. However, in the 
Vega de Oropouche group tested, there were 8 children 10 years of age or 
less. Only 2 of these children showed antibody, whereas 7 of 10 children 
11 years of age or more had type 1 antibody. Thus, the results in the 
Vega de Oropouche school children may have been weighted by the inclusion 
of the younger age group. 
Sera studied at the TRVL in 1963-64 (1964-65 Annual Report) indicated 
an incidence of poliovirus type 1 antibody of about 70% in 10 year olds. 
Excepting the younger age group in the Vega de Oropouche school, 70%, 67%, 
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antibody (median ages of these groups, excluding the younger group just 
indicated, were 12, 11, and 12 years, respectively). These results seem 
generally comparable to the earlier TRVL results, although studies of 
larger numbers of children in the various age groups would be necessary 
for more precise data. 
B. Performed at the Center for Disease Control (ADC), Atlanta, Georgia. 
Twelve original rectal swab extracts found by TRVL to contain a polio-
virus (10 type 1, 2 type 2) were studied at CDC to attempt to confirm 
the original results. All 10 poliovirus type 1 isolations and typings were 
confirmed. One extract which had yielded poliovirus type 2 at TRVL was 
found to contain poliovirus type 3 at CDC (TRVL No. 115220). A second 
extract from which type 2 virus was recovered at TRVL failed to reveal 
any virus at CDC (TRVL No. 115049). The TRVL isolant from this extract had 
been confirmed in Trinidad as a poliovirus type 2 with reagents from 
Atlanta as indicated above. The discrepancy between TRVL and CDC on the 
one extract yielding type 2 and type 3, respectively, cannot readily be 
Akplained. The failure to isolate type 2 virus from the other extract 
at CDC could have been due to inactivation of virus in storage and 
transport. All 12 of the rectal swab extracts were negative following 
inoculation of less than 24 hour old mice. 
Thirty-five tissue culture isolants from GDVL-TRVL were passed in primary 
rhesus kidney tissue cultures at CDC and set up against poliovirus anti-
sera to attempt to confirm typings done at GDVL-TRVL. Thirty-two of 
these isolants were confirmed as poliovirus type 1. Results on the 
remaining three were: 
TRVL CDC 
TRVL NO. 115518 Poliovirus type 1 Poliovirus type 3 
TRVL No. 115459 Poliovirus type 1 Poliovirus type 2 
TRVL No. 115793 Poliovirus type 1 no virus recovered. 
No ready explanation can be offered for the two discrepancies in typing. 
Failure in Atlanta to recover virus from one TRVL tissue culture could 
have been due to inactivation of virus during storage and transport. 
Viral isolation studies were repeated on the central nervous system 
tissue from the two fatal cases, using fresh pieces of each tissue. Fluid 
tissue culture, agar overlay tissue culture and suckling mice (<24 hours old) 
were used to test each specimen. Results are shown in Table 2. 
Only poliovirus type 1 was isolated from these two cases. Fecal 
material on the two patients also yielded this virus. The agar overlay 
technique allowed isolation of poliovirus type 1 from some tissues 
where fluid tissue culture methods failed to reveal the virus. Isolation 
of only poliovirus type 1 from the central nervous system tissues of these 
two cases both in Trinidad and in Atlanta proves that this virus was the 
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In summary, a total of 47 GDVL-TRVL virus isolants were confirmed as 
poliovirus type 1 (15 in Trinidad, 32 in Atlanta). Of these 47 cases, 
31 had no history of recent polio vaccination, 8 gave a history of 
vaccination within one month, and 8 had an unknown vaccination history. 
The significance of the isolation of poliovirus type 1 from the 8 cases 
with a history of vaccination within one month is uncertain, since 
vaccine virus might have persisted in these patients for this length 
of time. In the 31 cases without a history of recent vaccination, 
however, the isolation of poliovirus type 1 can be considered a valid 
indication of the poliovirus type involved in the illnesses. One polio-
virus type 2 isolant was also confirmed in Trinidad. In only 3 instances 
were there differences between the TRVL and CDC findings on tissue 
culture isolants. Ten of twelve original isolations from rectal swabs 
were repeated and confirmed as poliovirus type 1. Two of these 10 cases 
had a history of polio vaccination within 1 month, 6 had no history of 
recent vaccination, and 2 had an unknown vaccination history. The 
significance of the isolation of poliovirus type 1 from the 2 cases with 
a history of recent vaccination is again uncertain. Isolation of 
poliovirus type 1 from the 6 cases without a history of recent vaccination, 
on the other hand, again indicates the poliovirus type involved in the 
outbreak. Poliovirus type 1 was isolated from central nervous system 
tissues of two fatal cases (isolation done both in Trinidad and Atlanta). 
Neither of these 2 cases had a history of recent polio vaccination. 
Overall, then, the virological findings show that the outbreak of poliomye-
litis was due to poliovirus type 1. There was excellent agreement between 
the virological results of the two laboratories using independent reagents 
and methods. 
ADDITIONAL STUDIES  
Seventy-nine rectal swabs were collected before vaccination at two health 
centers (Barataria and Santa Cruz) from children 6 months to 12 years of 
age. Viral isolation studies at TRVL revealed poliovirus type 1 in 3 of 
these children. 
One hundred three blood samples were collected at the same two health 
centers on children before vaccination. Other blood samples were made 
available by TRVL as follows: 
.(a) Santa Cruz area -- 32 pairs (First serum collected previously for 
TRVL studies, second collected during 1971-72 poliomyelitis outbreak) 
(b) Vega de Oropouche, Plum Mitan, Plum Road, Grosvenor, Tabaquite 
and Caparo schools -- 48 pairs (First and second sera collected as above). 
(c) From areas (a) and (b) 	78 single sera (collected during 1971-72 
poliomyelitis outbreak). 
(d) Stephens Clinic, St. James Health Center - 36 single sera (collected 
before vaccination at these health centers). 
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Poliovirus antibody studies are planned on these sera to gather further 
data concerning pre-vaccination antibody status of children in Trinidad. 
PROBLEMS CONCERNING USE OF ORAL POLIOVACCINE 
Numerous questions were raised about the storage and use of oral polio-
vaccine. Principal among these were how long the vaccine would remain 
usable if stored refrigerated rather than frozen, how many times unopened 
vials of vaccine could be thawed and refrozen, and how long the remaining 
contents of an opened vial could be used. A set of recommendations was 
provided to the Ministry of Health covering these points (see Annex II). 
The recommendations were based on those given by American producers of 
vaccine and should, if adhered to, maintain potency of the vaccine. Other 
questions frequently raised concerned the use of oral poliovaccine in 
pregnant women and in the presence of other infections (respiratory ill-
ness or diarrhea, mainly). No written recommendations covering these 
points were prepared. Some general guidelines available in writing would 
probably be useful in similar situations. 
CONCLUSIONS 
1. Virological studies clearly indicated that the poliomyelitis 
epidemic was due to type 1 poliovirus. 
2. Storage facilities provided for oral poliovaccine by the Ministry 
of Health were less than optimal. Similarly, storage facilities in the 
outlying health centers need to be improved. 
3. There is a need for obtaining and disseminating information con-
cerning storage and use of oral poliovaccine, both within the Ministry 
of Health and to private physicians. 
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RECOMMENDATIONS TO THE GOVERNMENT OF TRINIDAD AND TOBAGO 
1. The Ministry of Health should establish a recommended set of condi-
tions for storage and handling of oral poliovaccine which will maintain 
the potency of the vaccine. These directions should be provided to all 
the outlying health centers. 
2. The Ministry of Health should obtain and disseminate information 
concerning the recommended use of oral poliovaccine. Such questions 
as those concerning use in pregnant women, use in the presence of inter-
current infection, and use in those already having had Salk vaccine 
should be covered in this information. 
3. The Ministry of Health should maintain its own facilities for storage 
of oral poliovaccine in the frozen state. Sufficient freezer space 
should be available at the main distribution center so that oral polio-
vaccine need not be sitting in cartons with dry ice while awaiting 
transportation to outlying areas. 
4. As soon as possible, the health centers should be provided with 
refrigerators having a freezer compartment with a separate door. In 
general, the freezer compartments of such refrigerators maintain better 
freezing conditions than freezer sections located within the refrigerator 
compartment itself. 
5. The Ministry of Health should carry out spot checks on storage of 
oral poliovaccine in the various health centers to determine whether the 
vaccine is being maintained frozen. Each health center should be required 
to keep an inventory of vaccine to include the date received. In this 
way, if storage facilities in any health center are not adequate to 
maintain poliovaccine frozen, the length of storage time in the liquid, 
refrigerated state could be controlled. 
6. The Ministry of Health should check commercial sources of oral 
poliovaccine to be sure that the vaccine supplied to private physicians 
is kept frozen before distribution. Physicians should also be informed 
of the proper storage conditions for and time limitations on the use of 
oral poliovaccine. 
7. Close liason should be maintained between the Ministry of Health and 
the Government Diagnostic Virus Laboratory - Trinidad Regional Virus 
Laboratory complex. Poliovirus isolation and typing facilities appear 
to be excellent at GDVL-TRVL. An increase in the number of poliovirus 
isolations should be followed closely to determine whether 
particular public health measures (for example, intensified immunization) 
are necessary. 
.0 
8. Laboratory studies to determine the antibody response after poliovirus 
immunization are recommended. These might give some indication of the 
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effectiveness of the immunization program, as well as suggesting 
problem areas (possible improper handling of vaccine, diminished 
seroconversion rate sometimes seen in tropical areas). 
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RECOMMENDATIONS TO THE PAN AMERICAN HEALTH ORGANIZATION 
1. The Pan American Health Organization should publish recommendations 
concerning the handling and storage of oral poliovaccine. Confusion 
exists because various producers of vaccine differ in their recommenda- 
V 	 tions. American producers (i. e., Lederle) recommend storage of oral 
poliovaccine for no more than 30 days in the liquid, refrigerated state 
(8°C or lower). Canadian producers (i. e., Connaught) indicate that 
vaccine can be kept for 90 days in the liquid, refrigerated state 
(4°C or lower). A practical recommendation, taking into account the 
fact that refrigeration facilities of unknown temperatures will be 
used in the field, should be issued. American producers of oral vaccine 
indicate that vials, once opened, must be used within 7 days (stored at 
8°C or lower). Connaught does not give any recommendation concerning use 
of opened vials. A French producer (Institut Merieux) says that "every 
vial which has been opened must be used on the same day." Again, a 
practical recommendation is needed. 
2. The Pan American Health Organization should provide recommendations 
concerning the use of oral poliovaccine. American producers of vaccine 
say that "pregnancy of itself is not a contraindication when immuniza-
tion is required." Canadian producers, in contrast, advise that "for 
pregnant women at any age inactivated poliomyelitis vaccine is recommended 
for primary immunization before administration of trivalent Sabin vaccine." 
Some resolution of this difference in recommendations should be provided. 
The question of whether the presence of another infection (diarrhea, upper 
respiratory illness) constitutes a contraindication to the administration 
of oral poliovaccine should be discussed. American producers of vaccine 
are fairly specific on their recommendations in such instances (i. e., 
postpone if there is persistent diarrhea or any acute illness, give if 
only minor upper respiratory infection is present). Definite guidelines 
should be provided for an epidemic situation. Another recurrent question 
in an epidemic situation is that of whether adults need to be immunized. 
Specific recommendations should be available. If monovalent poliovaccine 
is used in attempting to stem an epidemic, recommendations concerning the 
type of vaccine to use in follow-up immunizations should be provided. 
3. The Pan American Health Organization should consider recommending the 
establishment of a regional storage facility for oral poliovaccine. Such 
a facility should stock both monovalent and trivalent vaccines. A 
virological laboratory should be associated with the storage facility to 
provide a check for poterry on vaccines in stock. This laboratory could 
also provide poliovirus isolation and identification services to those 
countries needing this type of assistance. 
4. The Pan American Health Organization should provide assistance in 
getting fresh supplies of tissue culture and other materials to any con-
sultant virologist sent to aid in studying a poliomyelitis outbreak. If 
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an existing laboratory is carrying out viral studies in relation to the 
epidemic, the Pan American Health Organization might consider providing 
assistance to this laboratory in manpower and supplies. 
ANNEX I 
COOPERATION RECEIVED FROM INDIVIDUALS AND ORGANIZATIONS  
Dr. Pierre Ardoin, Chief, Trinidad Regional Virus Laboratory 
Miss Barbara Hull, Trinidad Regional Virus Laboratory 
Mr. Harold Drysdale, Government Virus Diagnostic Laboratory 
Nurse Bishop, Trinidad Regional Virus Laboratory 
Dr. Mervyn Henry, Ministry of Health, Trinidad and Tobago 
Dr. J. Monrose, Ministry of Health, Trinidad and Tobago 




MINISTRY OF HEALTH  
GOVERNMENT OF TRINIDAD AND TOBAGO  
RECOMMENDATIONS FOR STORAGE OF ORAL POLIOVIRUS VACCINE 
1. Bulk vaccine should be stored frozen as close to -20°C as possible. 
Under these conditions, the vaccine retains potency to the expiration 
date indicated on the containers. 
2. Vaccine kept in the liquid state under refrigeration (no higher 
than 8°C) should be used within 30 days. This is the recommendation 
of American producers of vaccine and is intended to assure potency 
of vaccine kept under refrigeration. 
3. Unopened vials of vaccine may be thawed and refrozen a maximum 
of 10 times if the temperature while thawed does not exceed 8°C 
and if the total cumulative duration of thaw does not exceed 24 hours. 
If the 24-hour period is exceeded, the vaccine must be used within 
30 days during which time it should be stored in the refrigerator at a 
temperature no higher than 8°C. Thus, unopened vials of vaccine not used 
on one day of a vaccination campaign should be refrozen for later use. 
When the total cumulative period of thaw is more than 24 hours, the 
vaccine must be used within 30 days. 
4. Vials of vaccine which have been opened must be used within 7 days 
during which time it should be stored in the refrigerator at a tempera-
ture no higher than 8°C. If the color of the vaccine in an opened vial 
changes from red or pink to yellow, the vial should be discarded because 
bacterial contamination may be indicated by the color change. 
5. Frozen vaccine must be agitated (shaken) after thawing to ensure 




VIROLOGICAL METHODS USED  
1. Rapid procedure for simultaneous isolation and identification  
of polioviruses.  
A. Prepare suspension from rectal swab; centrifuge and treat 
with antibiotics (penicillin, streptomycin, neomycin, 
amphotericin B). 
B. Mix a portion of the suspension with an equal volume of: 
a. Pool of poliovirus 1, 2, and 3 antibodies (50 units each 
antibody) 
b. Poliovirus type 1 antibody (50 units) 
c. Poliovirus type 2 antibody (50 units) 
d. Poliovirus type 3 antibody (50 units) 
C. Incubate 1-2 hours at room temperature. 
D. Inoculate 2 tubes of rhesus monkey kidney cells each with 0.2 ml 
samples of above rectal swab suspensions, antibody mixtures. 
E. Incubate tubes at 36° and observe microscopically for cytopathic 
effect. 
EXPECTED RESULT IN PRESENCE OF ANTIBODIES AGAINST: 
Virus type Polio- Polio- Polio- All 3 
indicated virus 1 virus 2 virus 3 Polioviruses 
Poliovirus 1 - CPE* + CPE + CPE - CPE 
Poliovirus 2 + CPE - CPE + CPE - CPE 
Poliovirus 3 + CPE + CPE - CPE - CPE 
Mixure of 
polioviruses + CPE 
+ CPE + CPE - CPE 
Other enterovirus + CPE + CPE + CPE + CPE 
No virus present - CPE - CPE - CPE - CPE 
Cytopathic effect 
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2. Standard procedure for isolation and typing of enteroviruses  
(including polioviruses) 
A. Prepare suspensions from rectal or throat swabs in tissue culture 
maintenance medium. 
B. Centrifuge 45 minutes at 8000 rpm in cold. 
C. Add antibiotics (penicillin, streptomycin, neomycin, amphotericin B); 
let stand 1 hour at room temperature. 
D. Inoculate primary rhesus kidney and diploid human embryonic lung 
tissue cultures and suckling mice. 
E. Incubate, observe for cytopathic effect in tissue culture or 
paralysis or death in suckling mice. 
F. If virus is found, titrate in appropriate system. 
G. Set up neutralization tests with 100 TCID
50 
(100 LD50 in mice) 
against known antisera (pools of antisera followed by indicated 
individual antisera; 20 antibody units for each antiserum). 
Titrate virus dilution used in test to check on dose of virus used. 
3. Neutralization tests for poliovirus antibodies in patients' sera. 
A. Inactive sera 30 minutes at 56°C. 
B. Prepare dilutions in tissue culture maintenance fluid (1:8). 
C. Add previously titrated stock polioviruses (100 TCID
50 
per 0.1 
D. Incubate 1 hour at room temperature. 
E. Inoculate two tissue culture tubes (HEp-2) with 0.2 ml each 
serum-virus mixture. 
F. Incubate at 35° for 6-8 days, observing for neutralization of 
cytopathic effect. 
G. Titrate virus dilution used in test to check on dose of virus used. 
ml for each 0.1 ml serum dilution). 
sl 
